News from the American Journal of Hematology
Rochester, Minn. – May 11, 2009 – Iron chelating drugs have been heavily promoted for use in patients with primary myelofibrosis (PMF), a form of blood cancer often treated with blood transfusion. These drugs, however, which withhold available iron in the body, are highly expensive and potentially toxic. Continue reading
This entry is part of a series, my fibro»
My son came home to find me on the floor and helped me to the sofa, He called my wife at work who called my doctor to see what to do, My Doctor immediately takes me off the Prozac and Amitripiline and said Continue reading
Information About Outcomes
Hemochromatosis can be treated effectively with phlebotomy (repeated blood removal). How well the treatment works depends on how much organ damage has already occurred before treatment begins. If hemochromatosis is found and treated early, complications can be prevented, delayed, or even reversed. With early diagnosis and treatment, a normal lifespan is possible. Continue reading
Treatments for hemochromatosis include therapeutic phlebotomy, iron chelation (ke-LAY-shun) therapy, changes in diet, and other treatments for complications.
Goals of Treatment
The goals of treating hemochromatosis are to reduce the amount of iron in your body to normal levels, prevent or delay organ damage from iron overload, treat complications of the disease, and maintain normal iron levels over the long term (for life). Continue reading
How Is Hemochromatosis Diagnosed?
Hemochromatosis is diagnosed based on your medical and family history, a physical exam, and diagnostic tests and procedures. The disease is sometimes found during the diagnosis of other diseases or conditions such as arthritis, liver disease, diabetes, heart disease, and impotence. Continue reading